ATXS
Astria Therapeutics Inc.
Company Overview
| Mkt Cap | $397.87M | Price | $12.63 |
| Volume | 621.72K | Change | +0.96% |
| P/E Ratio | -4.2 | Open | $12.51 |
| Revenue | -- | Prev Close | $12.51 |
| Net Income | $-94.3M | 52W Range | $3.56 - $12.72 |
| Div Yield | N/A | Target | $25.00 |
| Overall | 67 | Value | 60 |
| Quality | -- | Technical | 75 |
No chart data available
Stock Overview
Updated DailyAstria Therapeutics Inc. (ATXS) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $12.63 with a market capitalization of $397.87 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ATXS with a volume of 622K shares. The stock opened down 0.00% from yesterday's close of $12.51. Current analyst estimates project earnings of $-2.09 per share for this year, with next year targeting $-2.24.
ATXS demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ATXS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 97.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:22 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATXS | $12.63 | +1.0% | 621.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Astria Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW